
Zhengye Biotechnology Holding Limited Stock Analysis & AI Score
Zhengye Biotechnology Holding Limited (ZYBT) has an ST Score of 28.8 (C-), driven by its Momentum (B-) and held back by its Growth (F). ZYBT last traded at $1.31.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Zhengye Biotechnology Holding Limited (ZYBT) has an ST Score of 28.8 (C-), driven by its Momentum (B-) and held back by its Growth (F). ZYBT last traded at $1.31.
- Strongest
- MomentumB-
- Weakest
- GrowthF
All factor grades
- MomentumB-
- ValuationC+
- Financial StrengthC
- ProfitabilityF
- GrowthF
Contact
ZYBT stock: frequently asked questions
What is ZYBT's ST Score?
Zhengye Biotechnology Holding Limited (ZYBT) has an ST Score of 28.8 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ZYBT a buy, hold, or sell?
Our ST Score grades it C- (28.8/100). The ST Score is a data-driven signal, not a recommendation.
What are ZYBT's factor grades?
Valuation C+, Profitability F, Financial Strength C, Momentum B-, Growth F.
What is ZYBT's valuation grade?
Zhengye Biotechnology Holding Limited (ZYBT) earns a valuation grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ZYBT's growth grade?
Zhengye Biotechnology Holding Limited (ZYBT) earns a growth grade of F, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ZYBT's profitability grade?
Zhengye Biotechnology Holding Limited (ZYBT) earns a profitability grade of F, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ZYBT's financial strength grade?
Zhengye Biotechnology Holding Limited (ZYBT) earns a financial strength grade of C, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.